[HTML][HTML] Saturated fats: what dietary intake?
JB German, CJ Dillard - The American journal of clinical nutrition, 2004 - Elsevier
Public health recommendations for the US population in 1977 were to reduce fat intake to as
low as 30% of calories to lower the incidence of coronary artery disease. These …
low as 30% of calories to lower the incidence of coronary artery disease. These …
Management of hypertriglyceridemia
RC Oh, JB Lanier - American family physician, 2007 - aafp.org
Hypertriglyceridemia is associated with an increased risk of cardiovascular events and acute
pancreatitis. Along with lowering low-density lipoprotein cholesterol levels and raising high …
pancreatitis. Along with lowering low-density lipoprotein cholesterol levels and raising high …
Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X …
K Chu, M Miyazaki, WC Man… - Molecular and cellular …, 2006 - Taylor & Francis
Stearoyl-coenzyme A desaturase (SCD) is the rate-limiting enzyme necessary for the
biosynthesis of monounsaturated fatty acids. In this study, we investigated the regulation of …
biosynthesis of monounsaturated fatty acids. In this study, we investigated the regulation of …
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early …
PE Lønning, J Geisler, LE Krag, B Erikstein… - Journal of Clinical …, 2005 - ascopubs.org
Purpose To evaluate potential detrimental effects of exemestane on bone and lipid
metabolism. Patients and Methods Postmenopausal women with early breast cancer were …
metabolism. Patients and Methods Postmenopausal women with early breast cancer were …
Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada
AK Gitt, H Drexel, J Feely, J Ferrières… - European journal of …, 2012 - journals.sagepub.com
Background: The prevalence of persistent lipid abnormalities in patients receiving statins in
primary and secondary care is needed to formulate recommendations for future treatment …
primary and secondary care is needed to formulate recommendations for future treatment …
Dietary supplementation with casein/cyanidin-3-O-glucoside nanoparticles alters the gut microbiota in high-fat fed C57BL/6 mice
Q Lyu, H Deng, S Wang, H El-Seedi, H Cao, L Chen… - Food Chemistry, 2023 - Elsevier
This study aims to investigate the dietary intervention effect of casein/cyanidin-3-O-glucoside
nanoparticles (Cs-C3G) on high-fat-diet (HFD) induced gut microbiota disorders. In HFD-fed …
nanoparticles (Cs-C3G) on high-fat-diet (HFD) induced gut microbiota disorders. In HFD-fed …
Pharmacotherapy for dyslipidaemia–current therapies and future agents
H Bays, EA Stein - Expert opinion on pharmacotherapy, 2003 - Taylor & Francis
Current lipid-altering agents that lower low density lipoprotein cholesterol (LDL-C) primarily
through increased hepatic LDL receptor activity include statins, bile acid sequestrants/resins …
through increased hepatic LDL receptor activity include statins, bile acid sequestrants/resins …
Lactation and changes in maternal metabolic risk factors
EP Gunderson, CE Lewis, GS Wei… - Obstetrics & …, 2007 - journals.lww.com
OBJECTIVE: To examine the relationship between duration of lactation and changes in
maternal metabolic risk factors. METHODS: This 3-year prospective study examined …
maternal metabolic risk factors. METHODS: This 3-year prospective study examined …
Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial
In vitro and in vivo studies have shown that punicic acid, a type of conjugated fatty acid and
the main constituent of pomegranate seed oil (PSO), has anti-atherogenic effects. The …
the main constituent of pomegranate seed oil (PSO), has anti-atherogenic effects. The …
Review of Garcinia mangostana and its Xanthones in Metabolic Syndrome and Related Complications
H Tousian Shandiz, BM Razavi… - Phytotherapy …, 2017 - Wiley Online Library
Metabolic syndrome is coexistence of abdominal obesity, hyperglycemia, hyperlipidemia
and hypertension that causes cardiovascular diseases, diabetes and their complications …
and hypertension that causes cardiovascular diseases, diabetes and their complications …